Insulin stacking versus therapeutic accumulation: understanding the differences.

Area of Science:

• Pharmacology
• Endocrinology
• Diabetes Management

Background:

• Insulin stacking, the repeated injection of prandial insulin at short intervals, increases hypoglycemia risk.
• New basal insulins with prolonged action raise concerns about potential stacking when dosed daily.
• Distinguishing inappropriate stacking from appropriate accumulation is crucial for safe insulin therapy.

Purpose of the Study:

• To differentiate inappropriate insulin stacking from the pharmacokinetically appropriate accumulation of long-acting basal insulins.
• To clarify the clinical implications of insulin dosing intervals on steady-state concentrations.
• To address clinician concerns regarding the use of once-daily long-acting basal insulins.

Main Methods:

• Literature review of insulin stacking, glucose-clamp, and clinical studies.
• Analysis of pharmacokinetic (PK) properties of various insulin formulations.
• Integration of clinical experience with published data.

Main Results:

• Theoretical PK principles are confirmed by clinical studies, showing that appropriate dosing algorithms prevent unwanted basal insulin stacking.
• Long-acting basal insulins achieve steady state slower but exhibit reduced peak-trough fluctuations for consistent 24-hour action.
• Recommended dosing and titration algorithms effectively mitigate excessive basal insulin concentrations.

Conclusions:

• Unwanted insulin stacking and hypoglycemia from frequent rapid-acting insulin doses are avoided with appropriate long-acting basal insulin dosing.
• Long-acting basal insulins allow for pharmacologic steady-state accumulation when dosed and adjusted correctly.
• Safe and effective diabetes management is achievable with appropriate use of ultralong-acting basal insulins.